Pharmacosmos has decided to supplement the already substantial organic growth of the three business units with Business Development activities with the goal of further expanding Pharmacosmos’ product portfolio through in-licensing or M&A deals. The objective is to capitalize on Pharmacosmos’ presence with own subsidiaries and significant commercial infrastructures in key markets across the world notably USA, China, Germany, UK, and Nordics which enables us harvest synergies through expansion of our current product portfolio. The focus will be on the Human Iron Business Unit.
Business Development as a separate function is newly established and now under the leadership of Michael Ryde, VP Corporate Development and former head of Pharmacosmos’ US subsidiary and currently still based in US.
Pharmacosmos has opened two positions as Director Corporate Business Development with main job being to scan the market and identify opportunities within the framework of Pharmacosmos’ BD Strategy, asses the attractiveness and relevance for Pharmacosmos and drive the opportunities through our defined process through involvement of other relevant functions in a close teamwork.
The Business Development strategy and processes are currently being finalized and the right candidate will also be involved in adapting the strategy and processes as we learn as an organization.
The Business Development team will consist of two Directors of Corporate Business Development and the VP of Corporate Development.
This role will cover and include project ownership in all areas of business development:
In each case, the candidate’s responsibility will be the driver of assigned Business Development projects from scouting, project setup and through to deal execution involving members from other functions gradually and more and more as the project progresses.
The candidate will coordinate BD projects going through Identifying Opportunities, building a Light Team, Build the Core Team, Built the DD Team including Regulatory assessment involving Medical Affairs, R&D, Regulatory Affairs, QA, Affiliates, business support staff, Supply Chain and Legal as appropriate.
If you have any questions or want to apply for this job, please contact:
Partner Ole Koch
CV and application should be in English.
The job is located in Holbæk, Sjælland.
Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.
Pharmacosmos has subsidiaries in US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt
You are now leaving Pharmacosmos.com. The website you are about to visit is a Pharmacosmos subsidary.
Do you wish to proceed?